Bioequivalence Study of Pediatric Formulations to Treat HIV Infection

NCT01469520 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
24
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Elim Pediatric Pharmaceuticals Inc.